NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)
批准号:
10673178
负责人:
Judith O Hopkins
金额:
$225.87万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-08-01 至 2025-07-31
关键词:
AccelerationAdvocateAftercareAppalachian RegionAreaCancer ControlCaregiversCaringCatchment AreaClinicalClinical OncologyClinical ResearchClinical TrialsCommunitiesCommunity Clinical Oncology ProgramCommunity HospitalsDevelopmentEducationEmergency MedicineEnsureEthnic OriginEvidence Based MedicineEvidence based practiceFloridaFundingGastroenterologyGeographic LocationsGeographic stateGoalsGynecologyHealthHospitalsInfrastructureLeadershipMalignant NeoplasmsMentorsMinority GroupsMonitorNational Cancer InstituteNational Clinical Trials NetworkNorth CarolinaOncologyOperative Surgical ProceduresOutcomePalliative CareParticipantPatientsPersonsPopulationPreparationPreventionPrimary CarePrincipal InvestigatorPrivate PracticeQuality of CareQuality of lifeRadiology SpecialtyResearchResearch InstituteResearch PersonnelRuralScientific Advances and AccomplishmentsSiteSite VisitSouth CarolinaSystemTennesseeTrainingUnderserved PopulationUrologyVirginiaage groupbasecancer carecancer health disparitycancer therapycare deliveryclinical imagingcommunity organizationsdata submissiondesignexperiencehealth care deliveryhealth care disparityhuman subject protectionimprovedinnovationmedically underservedmedically underserved populationmembermetropolitannext generationoperationpatient populationperformance siteprecision medicineprogramsrecruitresearch studyrural underservedscreeningtargeted treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SCOR Project Summary/Abstract
The Southeast Clinical Oncology Research Consortium (SCOR) is a unique organization
comprised of 21 community members from rural and metropolitan areas under the leadership of
three experienced Principal Investigators (PIs), a Leadership Council, and the SCOR
Operations Center (SOC). The members comprise small community hospitals, hospital systems,
and private practices in a six-state geographical area (Florida, Georgia, North Carolina, South
Carolina, Tennessee, and Virginia). The primary goal of this application is to bring NCI clinical
trials and Cancer Care Delivery Research (CCDR) to the catchment area. A second goal is to
facilitate the use of effective, evidence-based practices to improve the quality of care, health
outcomes, and reduce cancer health care disparities. There are currently 230 investigators and
160 clinical research staff across 93 treatment performance sites engaged in National Cancer
Institute (NCI) research. Each community has a Community Responsible Investigator to oversee
research and to ensure human subjects protection. SCOR has a Young Investigator Mentoring
Program designed to increase participation of the next generation of NCI investigators in cancer
clinical research. Each community also has a research coordinator who is responsible for
clinical operations. The SCOR catchment area includes over 16 million people with significant
ethnic, rural, and medically underserved populations. The SOC in Winston-Salem, NC provides
extensive expertise, regulatory assistance, training, monitoring, mentoring, education, and
coordination to facilitate member community’s ability to provide clinical trials to their patient
population. SOC staff conducts at least yearly site visits to each community member to review
their research program and recruitment strategies, to ensure compliance and quality data
submission, and to assist with audit preparation. This infrastructure allows understaffed member
communities to conduct NCI clinical research. The efficient, centralized SOC and experienced
PI leadership will facilitate accomplishment of the goals of this application.
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1200/jco.22.00912
发表时间:
2022-07-20
期刊:
JOURNAL OF CLINICAL ONCOLOGY
影响因子:
45.3
作者:
[Reckamp, Karen L., Redman, Mary W., Dragnev, Konstantin H., Minichiello, Katherine, Villaruz, Liza C., Faller, Bryan, Al Baghdadi, Tareq, Hines, Susan, Everhart, Leah, Highleyman, Louise, Papadimitrakopoulou, Vassiliki, Gandara, David R., Kelly, Karen, Herbst, Roy S.]
通讯作者:
Herbst, Roy S.
DOI:
10.1016/j.cllc.2020.09.013
发表时间:
2021-05
期刊:
Clinical lung cancer
影响因子:
3.6
作者:
[Waqar SN, Redman MW, Arnold SM, Hirsch FR, Mack PC, Schwartz LH, Gandara DR, Stinchcombe TE, Leighl NB, Ramalingam SS, Tanna SH, Raddin RS, Minichiello K, Bradley JD, Kelly K, Herbst RS, Papadimitrakopoulou VA]
通讯作者:
Papadimitrakopoulou VA
Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.
palbociclib(PD-0332991)在CCND1、2或3扩增中的II期研究:NCI匹配ECOG-ACRIN试验(EAY131)子协议Z1B的结果。
DOI:
10.1158/1078-0432.ccr-22-2150
发表时间:
2023-04-14
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[]
通讯作者:
Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405.
CALGB转移性结直肠癌的体重指数和体重减轻(联盟)/SWOG 80405。
DOI:
10.1093/jncics/pkaa024
发表时间:
2020-06
期刊:
JNCI cancer spectrum
影响因子:
4.4
作者:
[Guercio BJ, Zhang S, Venook AP, Ou FS, Niedzwiecki D, Lenz HJ, Innocenti F, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, Fuchs CS, Meyerhardt JA]
通讯作者:
Meyerhardt JA
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
A041202 研究的后续研究表明,依鲁替尼疗法对患有 CLL 的老年患者持续有效。
DOI:
10.1182/blood.2023021959
发表时间:
2024
期刊:
Blood
影响因子:
20.3
作者:
[Woyach,JenniferA, PerezBurbano,Gabriela, Ruppert,AmyS, Miller,Cecelia, Heerema,NylaA, Zhao,Weiqiang, Wall,Anna, Ding,Wei, Bartlett,NancyL, Brander,DanielleM, Barr,PaulM, Rogers,KerryA, Parikh,SameerA, Stephens,DeborahM, Brown,Jenn]
通讯作者:
Brown,Jenn
共 18 条
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)
-
批准号:10476996
-
项目类别:
-
资助金额:$362.62万
-
财政年份:2014
-
负责人:Judith O Hopkins
-
依托单位:
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)
-
批准号:10227736
-
项目类别:
-
资助金额:$311.79万
-
财政年份:2014
-
负责人:Judith O Hopkins
-
依托单位:
海外基金